Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0030 (-99.97%)
Aug 18, 2025, 4:00 PM EDT
Biora Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2019 |
Net Income | -31.54 | -124.12 | -38.16 | -247.41 | -192.53 | -148.04 | Upgrade |
Depreciation & Amortization | 0.44 | 0.56 | 0.91 | 1.44 | 1.44 | 4.68 | Upgrade |
Other Amortization | 3.69 | 1.6 | 1.42 | 1.57 | 3.66 | 1.67 | Upgrade |
Loss (Gain) From Sale of Assets | 0.01 | 0.02 | 0.54 | 0.1 | 0.07 | - | Upgrade |
Asset Writedown & Restructuring Costs | - | 0.1 | 0.55 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | 3 | 3 | -5.73 | - | - | - | Upgrade |
Stock-Based Compensation | 5.94 | 16.48 | 7.8 | 11.96 | 8.24 | 2.38 | Upgrade |
Other Operating Activities | -39.45 | 45.25 | -28.86 | 117.87 | 145.95 | 40.24 | Upgrade |
Change in Accounts Receivable | - | - | - | - | - | 3.43 | Upgrade |
Change in Inventory | - | - | - | - | - | -3.86 | Upgrade |
Change in Accounts Payable | 1.93 | -1.17 | -5.07 | -8.69 | 2.83 | 4.38 | Upgrade |
Change in Income Taxes | -0.05 | -0 | -0.83 | 0.08 | 0.64 | 5.56 | Upgrade |
Change in Other Net Operating Assets | 10.1 | 9.79 | 1.25 | -17.26 | -63.24 | -16.56 | Upgrade |
Operating Cash Flow | -45.92 | -48.5 | -64.42 | -167.49 | -165.74 | -106.12 | Upgrade |
Capital Expenditures | -0.28 | -0.1 | -0.79 | -0.86 | -3.87 | -3.73 | Upgrade |
Sale of Property, Plant & Equipment | 0.02 | 0.01 | - | - | - | - | Upgrade |
Investment in Securities | 3 | - | - | - | - | 20.25 | Upgrade |
Other Investing Activities | 2.54 | 2.54 | - | -0.39 | -1.07 | - | Upgrade |
Investing Cash Flow | 5.28 | 2.44 | -0.79 | -1.24 | -4.94 | 16.53 | Upgrade |
Long-Term Debt Issued | - | 10 | - | - | 99.71 | - | Upgrade |
Long-Term Debt Repaid | - | - | -0.01 | -1.64 | -0.74 | -1.28 | Upgrade |
Net Debt Issued (Repaid) | 20.81 | 10 | -0.01 | -1.64 | 98.97 | -1.28 | Upgrade |
Issuance of Common Stock | 11.54 | 18.14 | 9.11 | 92.78 | 116.44 | 0.55 | Upgrade |
Common Dividends Paid | - | - | - | - | - | -4.5 | Upgrade |
Other Financing Activities | -1.08 | 2.64 | -1.8 | 73.92 | -6.99 | -0.18 | Upgrade |
Financing Cash Flow | 31.28 | 30.78 | 7.3 | 165.05 | 229.72 | 73.64 | Upgrade |
Net Cash Flow | -9.37 | -15.28 | -57.91 | -3.68 | 59.03 | -15.96 | Upgrade |
Free Cash Flow | -46.2 | -48.6 | -65.21 | -168.34 | -169.62 | -109.85 | Upgrade |
Free Cash Flow Margin | -5179.71% | -1215050.00% | -21380.00% | -13499.68% | -104700.62% | -76.29% | Upgrade |
Free Cash Flow Per Share | -15.33 | -30.81 | -85.41 | -437.68 | -1541.23 | -5624.34 | Upgrade |
Cash Interest Paid | 1.33 | 2.28 | 5.87 | 7.54 | 3.93 | 7.53 | Upgrade |
Cash Income Tax Paid | 0.07 | 0.02 | 0.03 | 0.37 | 0.06 | 0.01 | Upgrade |
Levered Free Cash Flow | -16.08 | 11.93 | -72.54 | -52.7 | -85.75 | -87.65 | Upgrade |
Unlevered Free Cash Flow | -15.19 | 16.46 | -67.09 | -46.37 | -83.21 | -83.57 | Upgrade |
Change in Working Capital | 11.98 | 8.62 | -4.65 | -25.86 | -59.78 | -7.05 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.